Focused on transformative treatment technologies in dermatology and oncology.
The Company's current focus is a range of dermatological applications utilising its unique formulation and delivery technologies to meet currently unmet needs in the skincare market.
Annual Report and Accounts 2025
Annual General Meeting 2025 recording
Incanthera unveils Skin + Cell skincare launch - One2One Investor Forum